65 yaş ve üzeri bireylerde son bir yıl içinde yapılan aşıların COVID-19 bulaşma ve seyrine etkisinin araştırılması
Küçük Resim Yok
Tarih
2021
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
İnönü Üniversitesi
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Amaç: COVID-19'un hızla yayılmasını önlemek ve insanları bu hastalıktan korumak için birçok araştırma yapılmaktadır. Bu çalışmada 65 yaş ve üzeri bireylere son bir yıl içinde yapılan aşıların COVID-19'un bu kişilere bulaşması ve bulaşan kişilerdeki klinik seyre bir etkisinin olup olmadığının araştırılması amaçlanmıştır. Gereç ve Yöntem: Araştırmamız Gözlemsel Tanımlayıcı tipte bir çalışma olarak yapılmıştır. Araştırmada kendi hazırladığımız anket kullanılmıştır. 65 yaş ve üzeri bireyler telefonla aranarak ya da Aile Sağlığı Merkezleri'nde yüz yüze anket yapılarak 09.12.2020-28.02.2021 tarihleri arasında araştırmamızın verileri elde edilmiştir. Araştırmaya dahil edilme kriterlerini karşılayan, rastgele seçilen; COVID-19 geçiren 520 kişi ve COVID-19 geçirmeyen 520 kişi araştırmamıza katılmıştır. Katılımcıların sosyodemografik verileri, kronik hastalıkları, tütün ürünleri ve alkol kullanımı, son bir yıl içinde yaptırdıkları aşılar ve COVID-19 ile ilgili soruları içeren anketten elde edilen veriler IBM SPSS Statistics 26 paket programı kullanılarak analiz edilmiştir. Bulgular: Çalışmamıza yaşları 65 ile 98 arasında değişen, rastgele seçilen; 520'si (%50,0) COVID-19 geçiren, 520'si (%50,0) COVİD-19 geçirmeyen, 499'u (%48,0) erkek, 541'i (%52,0) kadın toplam 1040 kişi katılmıştır. Katılımcıların 317'si (%30,5) son bir yıl içinde herhangi bir aşı yaptırmışken 723'ü (%69,5) ise yaptırmamıştır. 100'ü (%9,6) İnfluenza Aşısı, 254'ü (%24,4) Konjuge Pnömokok Aşısı (KPA13) ve 11'i (%1,1) de diğer aşıları yaptırmıştır. Sonuçlar: Son bir yıl içinde KPA13 yaptıranların yaptırmayanlara göre COVID-19'u daha az geçirdiği istatistiksel olarak anlamlı bulunmuştur. (Pearson Kİ-kare, p<0,001) Son bir yıl içinde İnfluenza Aşısı yaptıranların yaptırmayanlara göre COVID-19'u yüzdesel olarak daha az geçirdiği görülmüşse de istatistiksel olarak anlamlı bulunmamıştır. (Pearson Kİ-kare, p>0,05) Anahtar Kelimeler: COVID-19, Aşılar, KPA13, İnfluenza Aşısı
Aim: A lot of research is being done to prevent the rapid spread of COVID-19 and to protect people from this disease. In this study, it was aimed to investigate whether the vaccines administered to individuals aged 65 and over in the last year have an effect on the transmission of COVID-19 to these individuals and on the clinical course of the infected individuals. Material and Method: Our research was conducted as an Observational Descriptive study. The questionnaire we prepared was used in the research. The data of our research were obtained between the dates of 09.12.2020-28.02.2021 by calling individuals aged 65 and over by phone or by making a face-to-face questionnaire at Family Health Centers. Randomly selected, meeting the inclusion criteria; 520 people who had COVID-19 and 520 people who did not have COVID-19 participated in our research. The data obtained from the questionnaire, which includes the sociodemographic data of the participants, their chronic diseases, tobacco products and alcohol use, the vaccines they have had in the last year and the questions about COVID-19, were analyzed using the IBM SPSS Statistics 26 package program. Results: Randomly selected, with ages between 65 and 98; 520 (50,0%) had COVID-19, 520 (50,0%) did not have COVID-19, 499 (48,0%) were men, 541 (52,0%) were women total 1040 people participated in our research. While 317 (30.5%) of the participants had any vaccination in the last year, 723 (69.5%) did not. 100 (9.6%) had Influenza Vaccine, 254 (24.4%) Conjugated Pneumococcal Vaccine (KPA13) and 11 (1.1%) other vaccines. Conclusion: It was found statistically significant that those who had KPA13 in the last year had less COVID-19 than those who did not. (Pearson CI-square, p <0,001) Although it was observed that those who had Influenza Vaccine in the last year had less COVID-19 compared to those who did not, it was not statistically significant. (Pearson CI-square, p> 0,05) Key Words: COVID-19, Vaccines, KPA13, Influenza Vaccine
Aim: A lot of research is being done to prevent the rapid spread of COVID-19 and to protect people from this disease. In this study, it was aimed to investigate whether the vaccines administered to individuals aged 65 and over in the last year have an effect on the transmission of COVID-19 to these individuals and on the clinical course of the infected individuals. Material and Method: Our research was conducted as an Observational Descriptive study. The questionnaire we prepared was used in the research. The data of our research were obtained between the dates of 09.12.2020-28.02.2021 by calling individuals aged 65 and over by phone or by making a face-to-face questionnaire at Family Health Centers. Randomly selected, meeting the inclusion criteria; 520 people who had COVID-19 and 520 people who did not have COVID-19 participated in our research. The data obtained from the questionnaire, which includes the sociodemographic data of the participants, their chronic diseases, tobacco products and alcohol use, the vaccines they have had in the last year and the questions about COVID-19, were analyzed using the IBM SPSS Statistics 26 package program. Results: Randomly selected, with ages between 65 and 98; 520 (50,0%) had COVID-19, 520 (50,0%) did not have COVID-19, 499 (48,0%) were men, 541 (52,0%) were women total 1040 people participated in our research. While 317 (30.5%) of the participants had any vaccination in the last year, 723 (69.5%) did not. 100 (9.6%) had Influenza Vaccine, 254 (24.4%) Conjugated Pneumococcal Vaccine (KPA13) and 11 (1.1%) other vaccines. Conclusion: It was found statistically significant that those who had KPA13 in the last year had less COVID-19 than those who did not. (Pearson CI-square, p <0,001) Although it was observed that those who had Influenza Vaccine in the last year had less COVID-19 compared to those who did not, it was not statistically significant. (Pearson CI-square, p> 0,05) Key Words: COVID-19, Vaccines, KPA13, Influenza Vaccine
Açıklama
Anahtar Kelimeler
Aile Hekimliği, Family Medicine
